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Abstract 
Meta-analyses are an important tool within systematic reviews to estimate the overall effect 
size and its confidence interval for an outcome of interest.  If heterogeneity between the 
results of the relevant studies is anticipated, then a random-effects model is often preferred 
for analysis. In this model, a prediction interval for the true effect in a new study also 
provides additional useful information. However, the DerSimonian and Laird method – 
frequently used as the default method for meta-analyses with random effects – has been long 
challenged due to its unfavourable statistical properties. Several alternative methods have 
been proposed that may have better statistical properties in specific scenarios. In this paper, 
we aim to provide a comprehensive overview of available methods for calculating point 
estimates, confidence intervals and prediction intervals for the overall effect size under the 
random-effects model. We indicate whether some methods are preferable than others by 
considering the results of comparative simulation and real-life data studies.  
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1 Introduction 
Systematic reviews and meta-analyses provide a method for collecting and synthesizing 
research and are often used to inform decision making. The number of these publications has 
increased substantially since the 1990s.1 Meta-analysis is a valuable technique to summarize 
study-specific results and often reduces bias and uncertainty from individual studies. 
Guidelines and Health Technology Assessment panels, as well as international organizations, 
including the World Health Organization, 2 the European Medicines Agency, 3 and 
governmental agencies worldwide, such as, the Canadian Agency for Drugs and 
Technologies in Health,4 the Institute for Quality and Efficiency in Health Care (IQWiG),5 
and the National Institute for Health and Clinical Excellence,6 recognize the need to ensure 
that the best available evidence informs clinical practice and health care decision making. 
This typically involves conducting a high-quality knowledge synthesis and meta-analysis. 
Quantitative results of meta-analyses of relevant studies, in the form of a point estimate and a 
confidence interval (CI) for the effect size parameter of interest, are invariably considered 
together with judgements about the quality of the evidence to produce recommendations for 
practice.7  
Quantification of uncertainty in the estimated overall effect size is important in the 
process of drawing conclusions from a meta-analysis. This uncertainty should ideally account 
for between-study heterogeneity in the intervention effects across study settings and 
populations.8,9 For this reason, the random-effects model is often employed, which includes a 
between-study variance parameter. The uncertainty of the estimate of the overall effect size 
can be described by the corresponding CI under the random-effects model, and its width 
depends on the magnitude of the between-study variance, the number of studies, the precision 
of the study-specific effect sizes, and the significance level. 10 
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The estimation of the CI for overall effect size is often conducted with the Wald-type 
method using a normal distribution, the inverse of the sum of the study weights, and the 
DerSimonian and Laird 11 estimator for the between-study variance, and this has been used 
routinely in many meta-analyses.12 However, numerous shortcomings of this approach have 
been raised, such that the CI for the overall effect size generally does not retain its coverage 
probability (i.e., the proportion of times that the interval includes the true value) and hence it 
underestimates the statistical error, producing overconfident results.12-18 This is mainly 
because the Wald-type CI is based on a large-sample approximation (in terms of the number 
of studies) and the number of studies is usually small. Typically, the number of studies 
synthesised in a meta-analysis in medical research is less than 20 19-23 suggesting that any 
large-sample approximation is likely to be inaccurate. Several attempts to improve the 
standard Wald-type CI approach have been suggested, each of which has different statistical 
properties. 
Another important aim in decision-making is the prediction of the true effect size in 
an individual (future) study and setting. Higgins et al. 24 suggested the use of prediction 
intervals under the random-effects model for this purpose. The use of prediction intervals has 
been promoted and although they have not often been employed in practice they provide 
useful additional information. 25,26 
In this paper, we aim to provide a comprehensive overview of available methods in 
the methodological literature for calculating a CI for the overall effect size under the random-
effects model, and to indicate whether some methods are preferable to others by considering 
the results of comparative simulation and real-life data studies. We also examine potential 
issues surrounding the computation of prediction intervals under the random-effects model. 
The article is structured as follows. In section 2 we present the conventional meta-
analytic models and set up our notation (section 2.1), and describe our review methodology 
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(section 2.2). In section 3 we describe the statistical methods found in our literature review. 
In section 3.1 we describe 15 identified methods to calculate a CI for the overall effect size. 
In section 3.2 we discuss the comparative performances of different methods for computing a 
CI for the overall effect size, as described in previous studies, and summarise 
recommendations made by their respective authors. In section 3.3 we discuss methods for 
computing prediction intervals. We conclude with a discussion of all intervals (confidence 
and prediction intervals) in section 4. 
2 Methods  
2.1 Meta-analysis models and notation 
The conventional fixed-effect and random-effects models are the two main meta-analysis 
models to synthesise the study results. 27 The random-effects model accounts for two sources 
of variation, quantified by the within-study variance (𝑣𝑖) and the between-study variance 
(𝜏2). When ?̂?2 = 0, the fitted random-effects model collapses to the fixed-effect model (also 
known as common effects model),28,29 and therefore the random-effects model can be 
considered a generalization of the fixed-effect model (i.e., that the fixed-effect model is a 
special case of the random-effects model). CIs under the fixed-effect model can have poor 
properties even for low but non-zero heterogeneity. 13,30  
Both the conventional fixed and random-effects models require an estimated effect 
size 𝑦𝑖 (such as log-odds ratio) and an estimated (within-study) variance 𝑣𝑖 (𝑣𝑎𝑟(𝑦𝑖) = 𝑣𝑖) 
from every included study 𝑖, 𝑖 = 1, … , 𝑘. The choice between the two models has been 
widely discussed in the literature 31-33 and summarized in the Cochrane Handbook. 9 In this 
paper, we focus on the random-effects meta-analysis model using inverse-variance weighting. 
Other techniques to combine study information to calculate the overall effect size are also  
available, such as weighting by sample size 34,35 or using confidence distributions. 36,37 Also, 
dichotomous outcomes do not require inverse-variance methods, as they can be modelled 
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directly using one-step models (e.g., -generalised linear mixed models). 38 The description of 
these methods is beyond the scope of this review.  
The conventional random-effects model assumes that the estimated effect size from 
the 𝑖th study 𝑦𝑖 is  
 
where the study-specific random error (𝜀𝑖), and the underlying true effect sizes in the 
individual studies (𝜃𝑖) are normally distributed as 
 
 
The random-effects estimated overall effect size ?̂?𝑅𝐸 and its variance can be estimated as 
 and   
with weights 𝑤𝑖,𝑅𝐸 = 1/(𝑣𝑖 + ?̂?
2), where it can be seen that these weights are the inverse of 
the estimated total study variances. Similarly, the fixed-effect weights can be calculated as 
𝑤𝑖,𝐹𝐸 = 1/𝑣𝑖, and the estimated overall effect size ?̂?𝐹𝐸 and its variance are given by 
 and   
The uncertainty in an estimated effect size for a given study, in relation to its study-
specific true effect size, is expressed via the within-study variance 𝑣𝑖. The standard approach 
described above assumes that the estimated within-study variances 𝑣𝑖 are fixed and known 
although they have to be estimated from the data. This assumption is justifiable when each 
study size is sufficiently large. The 𝑣𝑖 estimation is not only sensitive to the study size, but 
also to the data type and effect size used. For example, the 𝑣𝑖 estimator in continuous 
outcomes when using the standardised mean difference depends on the estimated effect size. 
Hence, although 𝑣𝑖 are assumed fixed and known, 𝑣𝑖 are in fact estimated with some 
uncertainty. An alternative way would be to estimate within-study variances from simulated 
individual patient data (if these are not available).39 Several authors point out that this 
𝑦𝑖 = 𝜃𝑖 + 𝜀𝑖 , 
 
𝜀𝑖~𝛮(0, 𝑣𝑖), 
𝜃𝑖~𝛮(𝜇, 𝜏
2). 
?̂?𝑅𝐸 =
∑ 𝑦𝑖𝑤𝑖,𝑅𝐸
∑ 𝑤𝑖,𝑅𝐸
 𝑣𝑎𝑟(?̂?𝑅𝐸) =
1
∑ 𝑤𝑖,𝑅𝐸
, 
?̂?𝐹𝐸 =
∑ 𝑦𝑖𝑤𝑖,𝐹𝐸
∑ 𝑤𝑖,𝐹𝐸
 
𝑣𝑎𝑟(?̂?𝐹𝐸) =
1
∑ 𝑤𝑖,𝐹𝐸
. 
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assumption could affect the estimation of the overall effect size, its variance, and related 
inferences. 13,40-44 Therefore, calculating study weights through within-study variances and 
assuming that they are known constants may have less desirable properties. This issue has 
previously been discussed and some attempts have been made to account for the uncertainty 
in the weights. 45-48 Hence, among other factors, the performance of the CI methods depends 
on how well we estimate the study weights. 
Similarly, the estimation of 𝜏2 is performed with some uncertainty, and this uncertainty 
depends on the size and number of studies in the meta-analysis, as well as the size of the 
between-study variability. Factors such as these have implications for the accuracy of the 
standard statistical methods described in this paper, which has motivated many of the 
attempts to improve this. There are also many methods to estimate 𝜏2, any of which can be 
used in some of the CI methods described below, and we refer to a previous publication on 
this topic. 49 Also, for a review of the simulation studies evaluating the comparative 
performance of 𝜏2 estimators we direct the reader elsewhere. 50 
2.2 Review methods 
We searched PubMed from inception until 29 April 2016 to identify full text research articles 
that describe or compare methods for calculating CI for 𝜇 in simulations or in real data sets. 
We scanned the references of the selected articles for additional relevant articles, and we 
conducted general internet searches using the web search engine Google. We also used our 
networks of professional collaborations to identify potentially relevant articles. We included 
all studies that report the development or comparison of methods to calculate a CI for the 
overall effect size under the random-effects model. We also included studies reporting on 
prediction interval methods identified from our internet searches and networks of 
collaborations. We excluded commentaries, abstracts, and studies written in languages other 
than English, and studies relating to the hypothesis tests for the overall effect size. We 
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restricted our investigation to CI methods developed under the random-effects meta-analysis 
model that assume the true study-specific effects are normally distributed, while we excluded 
CI methods developed for network meta-analysis, one-stage individual patient data meta-
analysis, meta-analysis of diagnostic test accuracy studies, meta-analysis of multiple 
outcomes, and meta-regression analysis. One reviewer (AAV) summarised methods and 
studies’ conclusions from each included article and recorded any conclusions from 
comparative articles (studies that compare at least two methods). The information extracted 
refers to the performance of the various methods and the judgements deducted about their 
related advantages, and this information was checked by all co-authors. Disagreements were 
resolved by discussion. The PubMed search strategy is included in Supporting File: Appendix 
1.  
We describe known properties of the methods in terms of coverage probability and CI 
width in section 3.2. The closer the coverage probability is to the nominal level (usually 0.95) 
the better the CI is considered to be. A CI is exact when the actual coverage equals the 
nominal coverage. The coverage probability is closely related to the type I error of the 
hypothesis test on the overall effect size: assuming the null hypothesis is true, one minus the 
type I error rate is the coverage probability. A further criterion for comparing methods is that 
methods that provide narrower CIs, whilst retaining the correct coverage probability, are 
preferable because they increase precision, and hence are more informative. All statistics 
presented in this paper refer to two-tailed tests.  
3 Results 
The database search returned 5628 matches in PubMed and 20 records identified through 
other sources and searching reference lists. In total, 69 publications met the eligibility criteria, 
which are listed in Supporting File; Appendix 2. We identified 15 methods to compute a CI 
for the overall effect size. The properties of those methods have been evaluated in 31 research 
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papers, of which 30 include a simulation study and 32 include a real-life data evaluation of 
two or more methods. Below we present the 15 identified approaches in 7 broad categories, 
and as a separate section we present the comparative results of the identified simulations and 
studies using real data sets (see Supporting File; Appendix 3 for simulation scenarios and 
study characteristics and Supporting File; Appendix 4 for a summary of performance 
measures in simulation studies). In Table 1 we summarize the methods available in several 
software options. 51
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3.1 Confidence Intervals for the overall effect size 
3.1.1  Wald-type (WT) methods 
i) Wald-type normal distribution (WTz) confidence intervals (method 1) 
The WTz approach is the most popular technique for calculating a CI for 𝜇, 11 and a 95% CI 
is given by 
 
where 𝑧0.975 is the 0.975 quantile of the standard normal distribution. Any 𝜏
2 estimator can 
be used when computing a WTz CI.49,52 This method often has coverage probability 
considerably below nominal 0.95 level 14,15,44,53-59 when 𝑘 is small and/or 𝜏2 is 
large.13,44,56,57,60-65 Brockwell and Gordon 13 stated that the greatest source of error in the 
method is the use of a normal approximation for ?̂?𝑅𝐸. Despite the widespread use of the WTz 
method, it ignores uncertainty of the estimates of 𝜏2 and 𝑣𝑖 in 𝑣𝑎𝑟(?̂?𝑅𝐸). 
ii) Wald-type t-distribution (WTt) confidence intervals (method 2) 
A slight modification of the WTz CI is the WTt approach, where the t-distribution with 𝑘 − 1 
degrees of freedom is used, as opposed to the normal distribution. Although the two 
distributions converge asymptotically, the t-quantile is usually larger than the z-quantile 
associated with the WTz method. Hence, the WTt approach results in a wider CI and was 
proposed in order to increase the coverage probability, especially when the number of studies 
is small.55,66 A 95% CI can be obtained by 
 
where 𝑡𝑘−1,0.975 is the 0.975 quantile of the t-distribution with 𝑘 − 1 degrees of freedom. Any 
𝜏2 estimator can be used to compute a WTt CI.49,52 
iii) Quantile approximation (WTqa) confidence intervals (method 3) 
?̂?𝑅𝐸 ± 𝑧0.975√𝑣𝑎𝑟(?̂?𝑅𝐸), 
?̂?𝑅𝐸 ± 𝑡𝑘−1,0.975√𝑣𝑎𝑟(?̂?𝑅𝐸), 
12 
Brockwell and Gordon 60 proposed the WTqa method as an alternative to WTz method in an 
attempt to achieve better coverage. The method resembles WTz and WTt, but instead of 
using normal or t distributions it approximates the 0.025 and 0.975 quantiles of the 
distribution of the statistic 
 
that are required for the 95% CI for 𝜇. Hence, the WTqa uses different quantiles than the ones 
used in the WTz and WTt approaches. Let 𝑏𝑘 be the quantile approximation function, which 
monotonically decreases as a non-linear function of 𝑘, then a 95% CI is calculated as  
 
The quantiles 𝑏𝑘 are estimated via a Monte Carlo simulation process of samples of the 𝑀 
statistic with 𝑏𝑘 equal to the average of 0.025 and 0.975 absolute quantiles of the distribution, 
thus accounting for any small asymmetry in the distribution of 𝑀 around zero.60 To obtain the 
function 𝑏𝑘, Brockwell and Gordon fit a regression equation for the quantiles as a function of 
𝑘. The resulting regression equation (for 𝑘 = 1,2, … ,30) is: 
 
 
However, both number of studies k and the magnitude of 𝜏2 may impact on the performance 
of the WTqa method, 60 and changes in the distribution of the within-study variances can 
importantly impact on 𝑏𝑘. 
67 Although WTqa approach has been criticized on the grounds 
that it is, at best, very difficult to obtain suitable critical values 𝑏𝑘 that apply to all meta-
analyses, 67 we include it in this paper for completeness. As a conservative approach, Jackson 
and Bowden 67 suggested the use of the standard normal quantile instead, and to assess the 
robustness of the findings via a sensitivity analysis of alternative quantiles. Brockwell and 
Gordon 60 developed the WTqa method using the DerSimonian and Laird11 estimator of 𝜏2, 
𝑀 =
?̂?𝑅𝐸 − 𝜇
√𝑣𝑎𝑟(?̂?𝑅𝐸)
, 
?̂?𝑅𝐸 ± 𝑏𝑘√𝑣𝑎𝑟(?̂?𝑅𝐸). 
𝑏𝑘 = 2.061 +
4.902
𝑘
+
0.756
√𝑘
+
0.958
ln(𝑘)
. 
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but WTqa could, in principle, be implemented for any alternative 𝜏2 estimator. However, it is 
not advised to develop the WTqa CI further. 67 
3.1.2 Hartung-Knapp/Sidik-Jonkman (HKSJ) confidence intervals (methods 4 and 5) 
Hartung and Knapp 14 and Sidik and Jonkman 15 independently introduced the HKSJ 
CI (method 4) to handle meta-analyses that include a small number of studies. This method is 
based on the 𝑆 statistic, which follows a t-distribution with 𝑘 − 1 degrees of freedom, 
 
with 
 
and 𝑞 =
𝑄𝑔𝑒𝑛
𝑘−1
, where 𝑄𝑔𝑒𝑛 is the generalized Q-statistic 
 
An asymptotic 95% CI for 𝜇 is given by  
 
Although the method does not take into account the uncertainty in 𝜏2, the use of a 
different statistical approximation to the usual Wald-type CI may improve accuracy. Also, the 
HKSJ method can be applied with any 𝜏2 estimator, and is exact for known variance 
components. 14 For meta-analysis software where this method is not available yet, IntHout et 
al. 16 suggested an approach to convert WTz CIs easily to HKSJ CIs. The extension to meta-
regression was investigated by Knapp and Hartung, 65 and a generalization of the method to 
multivariate meta-analysis was explored by Jackson and Riley. 68  
When all variance components, including the between-study variances, are fixed and 
known, the expected value of 𝑄𝑔𝑒𝑛 is 𝑘 − 1, which equals the degrees of freedom of the 
associated  𝜒2 distribution.69-71 Hence, the small-sample adjustment 𝑞 will tend to be close to 
1. However, 𝑞 may in fact turn out to be even smaller than 1, such as in cases where the 
𝑆 =
?̂?𝑅𝐸 − 𝜇
√σ𝑤,?̂?𝑅𝐸
2
~𝑡𝑘−1, 
σ𝑤,?̂?𝑅𝐸
2 = 𝑞 ∙
1
∑ 𝑤𝑖,𝑅𝐸
= 𝑞 ∙ 𝑣𝑎𝑟(?̂?𝑅𝐸), 
𝑄𝑔𝑒𝑛 = ∑ 𝑤𝑖,𝑅𝐸(𝑦𝑖 − ?̂?𝑅𝐸)
2. 
?̂?𝑅𝐸 ± 𝑡𝑘−1,0.975√σ𝑤,?̂?𝑅𝐸
2 . 
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effect sizes are very homogeneous or when the number and/or size of studies is small. This 
leads to a narrower CI than the WTt approach and can also lead to a narrower CI compared to 
the WTz method. 72,73 Although the t-quantile is always larger than the z-quantile associated 
with the WTz method, explaining in part why the HKSJ CI performs better than the WTz CI, 
in the case of √𝑞 < 𝑧0.975/𝑡𝑘−1;0.975 the HKSJ CI will be narrower than the WTz CI. 
Wiksten et al. 72 show that if ?̂?2 = 0 then we estimate 𝑣𝑎𝑟(?̂?𝑅𝐸) = 𝑣𝑎𝑟(?̂?𝐹𝐸), and 
further that the variance of the estimate of 𝜇 simplifies to σ𝑤,?̂?𝑅𝐸
2 = (𝑄/(𝑘 − 1)) ∙ 𝑣𝑎𝑟(?̂?𝐹𝐸), 
with 𝑄 = 𝑄𝑔𝑒𝑛|(?̂?2=0) and 𝑄 ≤ (𝑘 − 1) when the DerSimonian and Laird
11 estimator of 𝜏2 is 
used. Therefore, the variance of the estimated effect size is always smaller or equal for the 
HKSJ method than the WTz method when the estimator of the between-study variance is 
zero. The possibility that the variance of the estimated effect size from the HKSJ method can 
be smaller than the variance of the WTz method was discussed by Knapp and Hartung,65who 
proposed a simple modification to the procedure. The authors suggested using 𝑞∗ instead of 𝑞 
(method 5) 65 
 
to ensure more conservative results. However, this practice may be overly conservative, 
leading to loss of power.74,75 
Sidik and Jonkman 15 recommend using the HKSJ CI, but instead of σ𝑤,?̂?𝑅𝐸
2  they 
suggest applying the sandwich variance estimator:  
 
 
This is a robust estimator of 𝑣𝑎𝑟(?̂?𝑅𝐸), where the inverse of the study weights (𝑤𝑖,𝑅𝐸
−1 = 𝑣𝑖 +
?̂?2) are estimated through the squared sample residuals ((𝑦𝑖 − ?̂?𝑅𝐸)
2) from the data, rather 
than assuming 𝑣𝑖 + ?̂?
2. 
𝑞∗ = max{1, 𝑞}, 
σ𝑆𝐽,?̂?𝑅𝐸
2 =
∑ 𝑤𝑖,𝑅𝐸
2 (𝑦𝑖 − ?̂?𝑅𝐸)
2
(∑ 𝑤𝑖,𝑅𝐸
2 )
2 . 
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However, Sidik and Jonkman 58 state that σ𝑆𝐽,?̂?𝑅𝐸
2  is biased when 𝑘 is small, and hence 
they suggest a bias corrected estimator of 𝑣𝑎𝑟(?̂?𝑅𝐸) (see Sidik and Jonkman 
58 for details). 
An alternative approach based on the expected information and on appropriately modified 
degrees of freedom of the t-distribution was suggested by Kenward and Roger. 76 These 
alternative expressions for 𝑣𝑎𝑟(?̂?𝑅𝐸) could also be used in Wald-type CIs but have not been 
adopted in practice so we do not explore their use further here.   
3.1.3 Likelihood-based methods 
i) Profile likelihood (PL) confidence intervals (method 6) 
The PL method has been established in meta-analysis by Hardy and Thompson 42 and is 
based on the likelihood ratio statistic, which unlike the WTz approach allows for asymmetric 
intervals. For 𝑦𝑖~𝛮(𝜇, 𝑣𝑖 + 𝜏
2), the log-likelihood function of the parameter vector (𝜇, 𝜏2) is 
given by 
 
Maximum likelihood estimates of (𝜇, 𝜏2) can be found by maximizing 𝑙𝑛𝐿(𝜇, 𝜏2) 
under the restriction 𝜏2 ≥ 0. The PL function is based on the log-likelihood function and uses 
an iterative process that provides CIs for 𝜇 that allow for the fact that 𝜏2 needs to be 
estimated as well. Since the PL approach profiles over 𝜏2, it accounts for, but does not fully 
allow for, the uncertainty in 𝜏2. This is because asymptotic results are required when using 
this method. However, the PL method is anticipated to be more accurate than the Wald-type 
methods in smaller samples. 
The profile log-likelihood for 𝜇 is defined as 
 
where ?̂?𝑀𝐿
2 (𝜇) is the maximum likelihood estimator for 𝜏2as 𝜇 varies. 42 A 95% CI for 𝜇 can 
be obtained as the values which satisfy (see Hardy and Thompson 42 equation 11): 
𝑙𝑛𝐿(𝜇, 𝜏2) = −
𝑘
2
𝑙𝑛(2𝜋) −
1
2
∑ 𝑙𝑛(𝑣𝑖 + 𝜏
2) −
1
2
∑
(𝑦𝑖−𝜇)
2
(𝑣𝑖+𝜏
2)
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𝑙𝑛𝐿𝑝(𝜇) = 𝑙𝑛𝐿(𝜇, ?̂?𝑀𝐿
2 (𝜇)), 
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where 𝜒1,0.05
2  is the 0.05 quantile of the 𝜒2-distribution with 1 degree of freedom. It has been 
shown that for small 𝑘 and 𝜏2, iterative algorithms are less likely to converge to a single 
value. 13 
ii) Higher-order likelihood inference methods (methods 7 and 8) 
As Reid 77 explains, the main asymptotic properties of likelihood-based inference include: (a) 
consistent, asymptotically normal and efficient maximum likelihood estimators; (b) an 
asymptotically normally distributed score statistic with mean zero; and (c) an asymptotic chi-
squared distributed likelihood ratio statistic. For example, the PL CI in the previous section 
relies upon the third of these standard results. As Reid 77 also explains, higher-order 
asymptotic results for likelihood based inference are also available. Some higher-order 
likelihood inference methods have recently been applied to meta-analysis, which is a 
situation where they may be thought to be especially valuable. This is because the number of 
studies is often small, so that the commonly used ‘lower-order’ asymptotic approximations to 
the likelihood function will be inadequate. Higher-order likelihood based methods therefore 
have the potential to produce more accurate results in meta-analysis and several proposals for 
this have been made. We briefly summarize the methods here but the details are technical and 
so we refer the reader to the articles cited below for more information.  
The Bartlett-type correction of the likelihood ratio statistic was first introduced by 
Bartlett (method 7). 78 Noma 17 explains how to apply this to random-effects meta-analysis, 
and so use a higher-order approximation than the PL method above. Noma 17 also explains 
how to use the score statistic to compute CIs, and subsequently derives a higher-order Bartlett 
type adjustment to this score. Skovgaard proposed an alternative higher-order approximation 
to the profile log-likelihood (method 8) 79 and Guolo 63 explains how to apply this to random-
effects meta-analysis. For details on the method we direct the reader elsewhere.63,80 The 
𝑙𝑛𝐿𝑝(𝜇) > 𝑙𝑛𝐿𝑝(?̂?𝑅𝐸) −
𝜒1,0.05
2
2
, 
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higher-order asymptotic methods have higher degree of accuracy, but in some cases (e.g., 
when the between-study variance is close to zero) they may produce numerically unstable 
maximum likelihood estimates due to the discontinuity of the statistic.63,80-82 In such cases, a 
bias reduction approach is suggested.83 Hence, the Bartlett-type correction (method 7) and the 
Skovgaard statistic (method 8) are the two main proposals for higher-order approximations 
when using methods based on the PL.63 
3.1.4 Henmi and Copas (HC) confidence intervals (method 9) 
Henmi and Copas 30 propose an alternative strategy for obtaining intervals for 𝜇 that are less 
sensitive to publication bias than the widely used WTz method. Since the fixed-effect 
estimates assign larger weight to bigger studies, and study size is one component among 
others that affects the overall effect size in the presence of publication bias, this method 
centres the CI on a fixed-effect estimate. This is because the fixed-effect estimates are less 
sensitive to publication bias than the random-effects estimates. To allow for heterogeneity, 
they first estimate the variance of the fixed-effect estimate under the random-effects model as  
 
 
Henmi and Copas 30 then derive an approximation to the resulting pivot 𝐺 that is used for 
making inferences about 𝜇 
 
assuming that the DerSimonian and Laird 11 estimator of the between-study variance is used.  
Hence approximate CIs can be computed. This can be thought of as a hybrid approach, where 
the fixed-effect estimate is accompanied by a CI that allows for between-study heterogeneity 
under the assumptions made in the random-effects model. A limitation of the approach is that 
the fixed-effect estimate is not fully efficient under the random-effects model, but Henmi and 
Copas 30 argue that it is “better to use a method that is more robust to publication bias, even if 
?̂? =
?̂?2 ∑ 𝑤𝑖,𝐹𝐸
2 + ∑ 𝑤𝑖,𝐹𝐸
(∑ 𝑤𝑖,𝐹𝐸)
2 . 
𝐺 =
?̂?𝐹𝐸 − 𝜇
√?̂?
, 
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this means sacrificing some efficiency under the standard setting”. A much simpler, but less 
accurate, way to implement Henmi and Copas’ idea would be to assume that the pivot 𝐺 
approximately follows a standard normal distribution, but this would ignore all uncertainty in 
the between-study variance. This simpler approach could also be used with alternative 
estimators of the between-study variance. Alternatively, one could apply the IVher model 
suggested by Doi et al.84 which uses quasi-likelihood approaches and is performed under the 
fixed-effect assumption. Doi et al.84 show that the IVher model favours larger trials, retains 
the nominal coverage probability, and exhibits lower variance of the overall effect size as 
opposed to the random-effects model irrespective of the degree of the between-study 
heterogeneity.  
3.1.5 Biggerstaff and Tweedie (BT) confidence intervals (method 10) 
Biggerstaff and Tweedie 85 proposed the use of different study-specific weights to those more 
conventionally used in the random-effects model, and estimated 𝜇 along with its variance 
using the weight 𝑤𝑖,𝑅𝐸
𝐵𝑇 , so as to acknowledge for 𝜏2 variability in the computation of CI for 𝜇. 
Acknowledging the uncertainty in the weights, allows greater uncertainty in the estimation of 
𝜇. 85 The 𝑤𝑖,𝑅𝐸
𝐵𝑇  weights are the expected value of the random-effects weights (calculated 
using the estimated 𝜏2) rather than the usual random-effects observed weights: 
 
The 𝑤𝑖,𝑅𝐸
𝐵𝑇  weights depend on the density form of 𝜏2, and were derived using the 
DerSimonian and Laird11 estimator for the between-study variance. Alternative estimators 
could also be used, in principle, when using this method, provided that their distribution, and 
so the expected weights used by the method, can be evaluated. The variance of ?̂?𝑅𝐸
𝐵𝑇 is 
estimated as 
 
𝑤𝑖,𝑅𝐸
𝐵𝑇 = 𝐸(𝑤𝑖,𝑅𝐸). 
𝑣𝑎𝑟(?̂?𝑅𝐸
𝐵𝑇) =
1
(∑ 𝑤𝑖,𝑅𝐸
𝐵𝑇 ) 2
∑(𝑤𝑖,𝑅𝐸
𝐵𝑇 )
2
(𝑣𝑖 + ?̂?
2). 
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Assuming normality, a 95% CI can be obtained as 
 
Biggerstaff and Tweedie 85 use an approximate distribution to obtain the expected weights, 
but this has been improved upon by Preuß and Ziegler 86 who used the exact weights through 
the exact cumulative distribution function of 𝑄, where 𝑄 = 𝑄𝑔𝑒𝑛|(?̂?2=0) .
87 Biggerstaff and 
Tweedie 85 provided the algorithm to implement the method in SAS. 
3.1.6 Resampling methods 
i) Zeng and Lin (ZL) confidence intervals (method 11) 
Zeng and Lin 88 examine the distribution of the estimated overall effect size under the 
random-effects model and find that it is not asymptotically normally distributed for a finite 
number of studies k. This makes intuitive sense, because the textbook result that a linear 
combination of normal random variables is normally distributed requires that the coefficients 
in this linear combination are constants. When estimating the overall effect size however 
these coefficients are proportional to the weights and so are functions of the estimated 
between-study variance. We require a large number of studies in order to estimate this 
variance accurately enough to treat the weights as fixed constants. 
Recognising that the estimated overall effect size is not asymptotically normally 
distributed for small k, Zeng and Lin 88 suggest a resampling procedure to obtain the 
distribution of this estimate, assuming that the DerSimonian and Laird11 estimator of 𝜏2 is to 
be used. Briefly, they simulate values of 𝜏2 using the DerSimonian and Laird11 estimating 
equation (where the individual study results used in this estimation are simulated from the 
fitted random-effects model). They then simulate estimated average effect sizes using the 
sampled 𝜏2 to calculate the weights in the estimating equation for ?̂?𝑅𝐸 (as given in section 
2.1, where the individual study results used in this estimation are simulated from the random-
?̂?𝑅𝐸
𝐵𝑇 ± 𝑧0.975√𝑣𝑎𝑟(?̂?𝑅𝐸
𝐵𝑇), 
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effects model centred at the estimated overall effect, and where the between study variance is 
taken to be the sampled value used to compute the weights). By repeating both aspects of this 
sampling process B times, B2 estimates provide an empirical distribution of estimated overall 
effects that can be used to compute confidence intervals and make inferences.88 This re-
sampling procedure could be modified to accommodate alternative estimators of 𝜏2, by 
instead calculating alternative estimates at the first stage, but this idea would need to be 
critically evaluated before it could be accepted.  
ii) Bootstrap confidence intervals (methods 12 and 13) 
Non-parametric bootstrapping is a way to approximate the sampling distribution of a statistic 
by resampling, from the sample itself, with replacement. Parametric bootstrapping instead 
samples from a fitted model. Both forms of bootstrapping can be used to make a variety of 
inferences but are most usually used to quantify the uncertainty in point estimates through the 
computation of standard errors and CIs. Briefly, bootstrap datasets are sampled (either non-
parametrically (method 12) 89,90 or parametrically (method 13)), 91 from which the bootstrap 
statistics (the statistic of interest calculated using the bootstrap datasets) are calculated. Then 
the empirical distribution of the bootstrap statistics is taken to approximate the distribution of 
the statistic of interest. Hence, measures of the uncertainty in the statistic, such as standard 
errors and CIs, can be calculated from this empirical distribution. In our context, this statistic 
is the estimated overall effect size. 
There is a variety of ways in which the bootstrap samples can be sampled under the 
random-effects model. For example, we could either sample estimated effect sizes and their 
standard errors directly, or instead sample the individual patient data in situations where this 
is available (this can readily be derived for dichotomous outcome data from the frequency 
and sample size). A full discussion of all the possibilities is beyond the scope of this paper, 
but Van Den Noortgate and Onghena 92 describe four different bootstrapping procedures, 
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where two of these are parametric and the other two are non-parametric. We refer the reader 
to this paper for full details of the sampling methods used. Parametric bootstrap CIs have also 
been advocated by Turner et al. 91 and non-parametric bootstrap CIs by Efron.93 
iii) Follmann and Proschan (FP) confidence intervals (method 14) 
Permutation tests have been suggested primarily to assess the true statistical significance of 
an observed finding under the null hypothesis of the absence of effect, especially in meta-
analyses with a small number of studies.94 This method can be extended and used for 
calculating CIs for the effect size. These tests are especially appropriate when the included 
studies in a meta-analysis may not be considered randomly sampled from a larger population 
of studies. Confidence intervals can be constructed by inverting hypothesis tests, where 
parameter values that are not rejected by the hypothesis test lie within the corresponding CI. 
Follmann and Proschan 55 begin by considering a permutation method for testing the 
null hypothesis 𝐻0: 𝜇 = 0. Their argument assumes that the distributions of the outcome data 
𝑦𝑖 are symmetric 
55 and this is implied by the random-effects model. Under the null 
hypothesis, the sign of 𝑦𝑖, is equally likely to be positive or negative for a symmetric 𝑦𝑖. 
There are 2𝑘 possible permutations of the signs of the values of the outcome data 𝑦𝑖. We take 
𝒁𝒑=(𝑍1
𝑝
, 𝑍2
𝑝
 ,…𝑍𝑘
𝑝
) to be the pth of these 2𝑘 permutations; for example with 𝑘 = 5 studies, 
(+1, +1, −1, −1, +1) is one of the 32 possible permutations. We define 𝑿𝒑 =
(𝑍1
𝑝 |𝑦1|, … 𝑍𝑘
𝑝 |𝑦𝑘|) to be the p
th permutation of the outcome data corresponding to 𝒁𝒑. The 
central idea is that, under the null hypothesis 𝐻0: 𝜇 = 0 and because the distributions of the 
𝑦𝑖 are symmetric, all 2
𝑘 permutations 𝑿𝒑 are equally likely. Hence, Follman and Proschan 55 
propose the null distribution where all values of  
      
?̂?𝑝 = ∑ 𝑤𝑖
𝑝𝑍𝑖
𝑝|𝑦𝑖| 
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are equally likely, where ?̂?𝑖
𝑝
 are the normalised (sum to one) random-effects weights 
described in section 2.1 where the between-study variance is estimated using 𝑿𝒑 as outcome 
data. Hence, ?̂?𝑝is the estimated average effect size using the pth permutation of signs of the 
outcome data. The 2-sided p-value based on the group permutation method proposed by 
Follmann and Proschan 55 is simply the proportion of the absolute values of ?̂?𝑝 that are more 
than or equal to the absolute value of the estimated average effect under the random-effects 
model using the observed data. Follman and Proschan 55 describe their procedure in terms of 
the DerSimonian and Laird11 estimator of the between-study variance, but, in principle, 
alterative estimators could be used. If k is too large for all permutations to be evaluated then 
the permutation distribution can be approximated by instead simulating a large number of 
permutations.55 
The procedure described above can be extended so that we instead test the hypothesis 
𝐻0: 𝜇 = 𝑐, and invert this hypothesis test to give the bounds of CIs. For further details on the 
FP method, we refer the reader to Follman and Proschan.55 This method has been suggested 
as an alternative approach to the Wald-type and likelihood-based approaches which assume 
normality of the observed effects, but it can be computationally demanding. The discrete 
nature of the permutation distribution will ensure that the CI maintains the desired coverage 
probability, but in general this coverage probability will be larger than the nominal level.  
3.1.7 Bayesian credible intervals (method 15) 
Bayesian credible intervals (CrIs) for the overall effect size can be obtained within a 
Bayesian framework using specialised software and the Markov Chain Monte Carlo 
(MCMC) technique, such as WinBUGS 95 or SAS PROC MCMC. Some advantages of the 
Bayesian approach include: 1) incorporation of uncertainty in model parameters (𝜇, 𝜏2), 2) 
derivation of CrIs from the posterior distribution, and 3) use of informative prior distributions 
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on the model parameters. However, the use of informative priors for the effect size 
parameters has been discouraged by some researchers due to potential inclusion of bias.96 The 
use of vague priors allows the analysis to remain data driven. On the contrary, the use of 
informative priors for the between-study variance has been suggested to increase confidence 
in the overall effect size, especially when few studies are included in a meta-analysis.20,21 
Informative priors for 𝜏2 under several treatment comparison types and outcome settings are 
available for dichotomous data 20 and for continuous data. 21 Friede et al. 97 suggest Bayesian 
CrIs perform well even in rare diseases with a small number of studies when the appropriate 
prior for 𝜏2 is applied. In rare diseases and small populations, the use of half-normal priors, 
with expectation 0 and variance 0.25 or 1 for 𝜏2, has been recommended when log-odds 
ratios are used to measure the effect size.97 Vague priors can also be applied for 𝜏2, but 
caution is needed as results are sensitive to the prior specification, especially when the 
number of studies is small.98 This is because the choice of prior may impact on the estimation 
of the between-study variance and consequently on the estimated overall effect size and the 
width of its CI. Other difficulties that have been associated with the derivation of Bayesian 
CrIs include the complication of determining whether convergence is achieved, the need to 
burn-in when using MCMC, and the impact of MC error. Alternative methods to implement a 
Bayesian meta-analysis are available by using numerical integration, importance sampling 
and data augmentation as described by Turner et al. and Rhodes et al. 99,100 For practical 
application the R package bayesmeta is available.101 
3.2 Comparative evaluation of the methods 
The properties of the 15 CI approaches have been evaluated in 31 research papers, including 
30 simulation studies and 32 real data evaluations of the methods (for simulation scenarios 
and study characteristics see Supporting File; Appendix 3). Published articles suggested that 
the different approaches can provide noticeably different or even conflicting results and their 
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performance can vary regarding coverage and CI width. Below we discuss the comparative 
results as presented in the identified studies. However, it is hard to compare simultaneously 
all 15 CI approaches, as they have never all been compared under the same conditions and 
simulation scenarios. The presentation of results follows the same CI presentation order with 
section 3.1. 
Wald-type methods (methods 1, 2, and 3) 
The performance of the popular WTz method has been assessed in several studies and 
it is poor when compared with other methods. Simulations suggest that the WTz performs 
worse in terms of coverage for small numbers of studies (𝑘 < 16) compared with the PL and 
the WTt methods, whereas for large k all three methods perform well.102 The performance of 
the WTz method though does not only depend on the number of studies, but also on the 𝜏2 
estimator employed and its magnitude.44 The WTz coverage has been found to differ by up to 
0.05 between different 𝜏2 estimators, up to 0.30 between meta-analysis samples, and up to 
0.20 across between-study variance values ranging from small to large 𝜏2. Coverage has been 
found to be as low as 0.65 (at 0.95 nominal level) when I2 (defined as the percentage of the 
total variability in a set of effect sizes that is due to between-study variability beyond what is 
expected by within-study random error) is 90% and two or three studies are included in a 
meta-analysis, but it tends towards the nominal level as the number of studies increases.52 
To increase coverage, the t-distribution can be used, which produces wider CIs than 
those obtained by the standard normal distribution, especially when 𝜏2 and 𝑘 are small.15,55 
The coverage probability is therefore higher with the WTt approach, but it depends on the 
estimator and the magnitude of 𝜏2, as well as on the number of studies.44 Simulation showed 
that the WTt CI is less affected by the number of studies compared to the WTz CI.64 
Although WTt coverage may be more robust to changes in the 𝜏2 magnitude compared with 
WTz when few studies are included in a meta-analysis, it has been found to differ by up to 
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0.05 depending on the 𝜏2 estimator used and the number of studies.52 For large meta-analysis 
samples (e.g., 𝑘 ≥ 20), the coverage of the 95% WTt CI may be below the nominal level, but 
it becomes conservative (close to 1) when 𝑘 is small.52,60,102 
Alternatively, the WTqa method is easy to implement and produces intervals with 
better coverage in comparison to the WTz method.60 A simulation study 44 showed that 
different estimators of the between-study variance may impact on coverage and that the 
WTqa method is associated with higher coverage than WTz and HKSJ CIs, but the HKSJ 
method produced values closer to the nominal level. The same study showed that the WTqa 
method has similar coverage to the WTt method. For small 𝑘, coverage of the WTt method is 
well above the nominal level and higher than that for the WTqa method, but as 𝑘 increases 
the differences in coverage are not so important.60 Simulations have also shown that WTqa 
outperforms WTz, PL, and ZL approaches, but it is very conservative.88 
Hartung-Knapp/Sidik-Jonkman methods (method 4 and 5) 
The HKSJ approach (method 4) is often preferred, as in case of small 𝑘 it is 
conservative and produces wider CIs with more adequate type I error compared with the WTz 
method.16,57,81,94,103 The HKSJ method provides exact inference when all study sizes are equal 
and the random-effects model is true, resulting in better inference than WTz, 104 but also 
provides more accurate inference in small meta-analyses with different study sizes. 14,15,54 
Several studies suggested that the HKSJ method has coverage close to the nominal level, and 
that it is not influenced by the magnitude or estimator of 𝜏2. 16,44,52,53,57,59,65,72,75,97 
Nevertheless, Knapp and Hartung 65 recommend using the PM 105 estimator for the between-
study variance along with the HKSJ method to obtain CIs for 𝜇 so as to get a cohesive 
approach based on 𝑄𝑔𝑒𝑛. 
105,106 Sanchez-Meca and Marin Martinez 44 recommend using the 
HKSJ method as it is additionally insensitive to the number of trials. Simulation studies 
suggest that HKSJ has good coverage when the effect measure is the log-odds ratio, 15,57 the 
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standardised mean difference, 59 the mean difference and the risk difference. 56 The coverage 
of the 95% HKSJ CI is generally better than the WTz and WTt coverages, but it is suboptimal 
in meta-analyses with binary outcomes and rare events, as shown in simulated meta-analyses 
where the odds-ratio was used as the measure of effect. 52 
A real-life data study of 920 Cochrane meta-analyses with 𝑘 ≥ 3, showed that the 
WTz method yielded more often statistically significant results compared with the HKSJ 
method (45% vs. 35% of meta-analyses).107 IntHout et al.16 found similar results in their real-
life data study with 434 Cochrane meta-analyses with dichotomous data (43% vs. 34%) and 
255 Cochrane meta-analyses with continuous data (51% vs. 40%). It is recommended that 
caution is needed when fewer than five studies of unequal sizes are included in the meta-
analysis. 16 Wiksten et al. 72 in their empirical evaluation including 157 meta-analyses with 
dichotomous data and 𝑘 ≥ 4, found that in the presence of heterogeneity (using the 
DerSimonian and Laird11 estimator [?̂?2 > 0] or the Cochran’s 𝑄 statistic [𝑝 < 0.10] 11,108) the 
p-value for the overall effect size was typically greater when using the HKSJ than the WTz 
method. However, they comment that the HKSJ method is not always more conservative for 
?̂?2 = 0.  
It has been shown that in the absence of heterogeneity the coverage of HKSJ may be 
smaller than the WTz coverage providing narrower CIs. 15,53,56,59,72,73,109 This was more 
prevalent in cases with rare events. 72 Jackson et al. 73 raise a variety of concerns about the 
use of the HKSJ method, including 1) the implications of the modification for any given 
meta-analysis are hard to predict , 2) HKSJ can result in shorter CIs for the overall effect size 
than the WTz method, and 3) the coverage of the HKSJ CI might be anticipated to be low 
when ?̂?2 = 0. However, in simulation studies conducted by Röver et al. 75, Viechtbauer et 
al.74 , and Sanchez-Meca and Marin Martinez 44 HKSJ worked well even in the absence of 
heterogeneity. This is in line with the simulations by Gonnermann et al. 110, but in the 
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presence of only two studies for 𝜏2 = 0, HKSJ is associated with very low power compared 
with WTz (15% vs. 60%), which may be due to the wider CI, whereas for mild to moderate 
𝜏2 both methods have poor control of type I error. A simulation study compared HKSJ with 
the small sample modification suggested by Knapp and Hartung 65 and indicated that the use 
of the modified HKSJ (method 5) is preferable when few studies of varying size and 
precision are available. 75 Another simulation study suggested the use of the modified HKSJ 
approach instead of the common HKSJ and WTz approaches when dichotomous data are 
considered. 111 However, for few studies (and particularly for 𝑘 = 2) and as the between-
study variance decreases, the modified HKSJ tends to be over-conservative, and selection 
between the methods is a matter of power vs. type I error. 73-75  
Likelihood-based methods (methods 6, 7, and 8) 
The PL method is often preferred to the WTz method, as it is associated with a higher 
coverage closer to the nominal level, even when 𝑘 is relatively small. 60,83 Jackson et al. 102 
showed that the PL method performed well and better than the WTz and WTt methods in 
meta-analyses with few studies (𝑘 ≤ 8) with coverage close to the nominal level. However, 
coverage decreases as 𝜏2 increases and/or 𝑘 decreases. 42 Simulations suggest that the PL CI 
is less affected by the number of studies in a meta-analysis compared to the WTz CI, but both 
WTz and PL have poor coverage control, as they yield values below the nominal level. 64 
Simulations found that the Bartlett-type correction CI (method 7) improves coverage 
properties over the WTz, WTt, and PL methods that their coverage deviates the nominal level 
as 𝜏2 increases and/or 𝑘 decreases. 17,64 Although the Bartlett-type correction CI has a 
satisfactory power compared to the WTz, WTt, and PL CIs, 64 and performs well when 𝜏2 =
0, 82 caution is needed for 𝑘 ≤ 5 as it tends to be over-conservative. 17 The Skovgaard 
statistic CI (method 8) is associated with coverage closer to the nominal level compared with 
the WTz and PL CIs, which is remarkable for small 𝑘. 17,63,81 Both the Skovgaard statistic CI 
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and the Bartlett-type correction CI perform very satisfactorily regarding coverage and yield 
similar results. 81 
Henmi and Copas and Biggerstaff and Tweedie methods (methods 9 and 10) 
Simulations showed that in the absence of publication bias and for 𝑘 > 10 the HC 
method yields better coverage than WTz, HKSJ, PL, and BT methods, whereas for 𝑘 < 10 
the HKSJ and PL methods perform best. 30 The same study showed that when publication 
bias is present and for 𝑘 > 10, HC improved coverage compared to WTz, HKSJ, PL, and BT 
methods, and showed less bias than the fixed-effect model. Also, the WTz and BT methods 
have comparable coverage probabilities with coverage below the nominal level, 60,86 but 
coverage is increased for the exact weights. 86 
Resampling methods (methods 11, 12, 13 and 14) 
Zeng and Lin 88 showed that the ZL CI outperforms both WTz and PL CIs for small 𝑘 
in terms of coverage. Another simulation study showed that the FP CI controls coverage 
better than WTz, WTt, PL, and is closely followed by the Bartlett-type correction CI, but the 
latter is slightly more powerful especially for small 𝑘. 64 The same study showed that the FP 
CI and the Bartlett-type correction CI were less affected by the number of studies than WTz, 
PL, and WTt methods. 
Bayesian credible intervals (method 15) 
Simulation studies showed that Bayesian intervals produce intervals with coverage 
closer to the nominal level compared to the HKSJ, modified HKSJ, and PL CIs, 97,112 and 
they tend to be smaller than the HKSJ CI even in situations with similar or larger coverage. 97 
However, the performance of the Bayesian CrIs may vary depending on the prior assigned to 
the between-study variance. 98 
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3.3 Prediction intervals 
One of the most important aims in clinical decision-making is the prediction of the 
possible effect size in an individual setting. A prediction interval provides a predicted range 
for the true effect size in a new study, and its calculation is recommended to be conducted 
under the random-effects model. 24,95 Assuming the random effects are normally distributed 
an ad hoc 95% prediction interval can be obtained by 
 
To date, this is the standard prediction interval approach used in meta-analysis. We 
call this prediction interval ad hoc, because 𝜏2 is unknown and currently there is no exact 
distributional form available. The use of a t-distribution instead of a normal distribution 
reflects the uncertainty resulting from the estimation of the heterogeneity. Higgins et al. 24 
also presented this ad hoc 95% prediction interval but instead using quantiles from the 𝑡𝑘−2 
distribution. However, we suggest using the t-distribution with consistent degrees of freedom 
for both CIs (e.g., see the WTt and HKSJ methods) and prediction intervals. This is because 
when there is truly no heterogeneity (𝜏2 = 0) the overall effect size and the true effect size in 
a new study are identical, so that CIs (for the overall effect size) and prediction intervals (for 
the true effect in a new study) should be identical. Taking the estimated between-study 
variance of zero to be the true value therefore gives rise to the intuition that CIs and 
prediction intervals should be identical when ?̂?2 = 0. In fact, in the metafor R package, 113 
the CIs and prediction intervals are always computed in a consistent manner: when a WTz CI 
is computed then a prediction interval is also calculated using a standard normal distribution, 
whereas when a HKSJ CI is computed then both CI and prediction interval are computed 
using the 𝑡𝑘−1 distribution. Hence, when ?̂?
2 = 0, the CI and prediction interval will coincide, 
as intuition suggests that they should. To date, other routines, including the meta 114 R 
package, the Stata metan 115 and Stata mvmeta 116 commands, calculate a prediction interval 
?̂?𝑅𝐸 ± 𝑡𝑘−1,0.975√?̂?2 + 𝑣𝑎𝑟(?̂?𝑅𝐸). 
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using consistently a t-distribution. Another advantage of using the 𝑡𝑘−1 distribution, is that 
for 𝑘 = 2, where a CI for the overall effect size is available, prediction intervals can be 
calculated. However, this is not the case when the 𝑡𝑘−2 distribution is used. Prediction 
intervals come especially naturally from a Bayesian approach, but at the price of specifying 
priors. 98 
It is worth noting that the prediction interval does not inform the statistical 
significance of ?̂?𝑅𝐸, it instead describes the region within which the true study effects of new 
studies are expected to be found. A prediction interval can help understand the uncertainty 
about whether an intervention is expected to work and reflects the potential effect in future 
study participants. 117 Prediction intervals are particularly helpful when excess between-study 
heterogeneity exists, and the combination of individual studies into an overall effect size 
would not be advisable. IntHout et al.118 found that in more than 70% of the statistically 
significant meta-analyses in the Cochrane Database of Systematic Reviews with ?̂?2 > 0, the 
95% prediction interval suggested that the effect size in a new study could be null or even in 
the opposite direction from the overall result in some patient populations. The prediction 
interval can also be used to calculate the probability that a new trial will have a negative 
result and to improve the calculations of the power of a new trial. Conclusions drawn from a 
prediction interval are based on the assumption the study effects are normally distributed. The 
prediction interval estimation will be imprecise if the estimates of the overall effect size and 
𝜏2 are away from the true parameter. However, concerns have been raised about the 
understanding of the properties of the prediction intervals, as 𝜏2 is unknown, the degrees of 
freedom (𝑘 − 2) can result in over-coverage when 𝑘 is small, the new unobserved study with 
unknown characteristics is difficult to conceptualise, and the estimation of the prediction 
interval is sensitive to the assumptions of the RE model. Further, Partlett and Riley 119 
assessed the performance of the ad hoc 95% prediction interval in a simulation study and 
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they concluded that the method is only accurate when heterogeneity is large (I2 > 30%) and 
the study sizes are similar. However, for small heterogeneity and different study sizes the 
coverage of prediction interval can be as low as 78% depending on the between-study 
variance estimator. 119 Lee and Thompson 120 further highlight the importance when 
calculating a prediction interval to allow for potential skewing and heavy tails in the random-
effects distributions. Prediction intervals can be implemented in several software, such as R 
(using for example metafor, 113 and meta 114 packages), Stata (using for example metan 115 
and mvmeta 116 commands). 
4 Discussion 
The estimation of the overall effect size is one of the primary aims in meta-analysis. 
Therefore, the computation of a confidence/credible interval is crucial in order to interpret the 
uncertainty in the estimated overall effect size. Wald-type methods, and in particular the WTz 
CI using the DerSimonian and Laird 11 estimator for the between-study variance, are 
commonly used and are the default option in several meta-analysis software (e.g., 
RevMan).130 However, the accuracy of these standard CI methods is not optimal, as the 
coverage probability associated with these CIs can deviate considerably from the nominal 
coverage probability in small meta-analyses. 12-18 This is not surprising as the Wald-type 
methods rely upon large-sample approximations requiring many studies to be included in a 
meta-analysis. However, meta-analyses often include a small number of studies, and large-
sample approximations can be inaccurate. 19-23 Perhaps because of this property, several other 
CI methods have been proposed to improve the standard Wald-type CIs, including likelihood-
based and resampling methods, and more recently, higher-order likelihood inference 
methods. In the present study, we provide a comprehensive review of the CIs for the overall 
effect size under the random-effects model. 
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Our review identified 15 methods for calculating a CI for the overall effect size, each 
of which has different statistical properties. The selection of a method for computing a CI 
should be based on its statistical performance according to the corresponding meta-analysis’ 
characteristics, as well as on the method’s computational and conceptual complexity. Usually 
one of these comes at the price of another. For example, the likelihood-based methods are 
associated with coverage closer to the nominal level compared to the commonly used WTz 
method, but are computationally more demanding than the WTz CI. Also, the use of some 
methods (e.g., ZL) is limited in meta-analyses, due to complex calculations with standard 
software or their unavailability in statistical software. Simulations have assessed the 
performance of various methods and showed that it mostly depends on the magnitude of the 
between-study variance and number of studies in a meta-analysis. However, additional items 
should be considered when selecting a CI. These may include the type of outcome data and 
the study size.  
The selection of the most preferable methods to calculate a CI for the overall effect 
size can be mostly based on coverage, as this measure was the only one consistently reported 
across the identified studies. The 15 methods identified in this review have never all been 
compared in one simulation study under the same conditions, and hence making any clear 
recommendations about these methods would be difficult. Also, none of the methods had an 
optimal coverage across all settings. Therefore, we can only offer tentative recommendations 
based on the available evidence, but these depend on the study findings, their simulation 
scenarios, and the CIs examined. It would require an extensive simulation study to assess the 
performance of all of these methods, under the same, realistic settings. Future studies should 
evaluate the CIs for all relevant properties, including coverage, precision, complexity, and 
power of the corresponding tests. In addition, further research is necessary to make 
judgements on the performance of CIs. In particular, a comprehensive simulation study 
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informed by real-life data included in a meta-analysis would help determine the factors that 
impact the performance of the CI methods. Factors to consider in this analysis may include: 
number and size of studies, baseline risk variability, magnitude and estimator of the between-
study variance, frequency of events in dichotomous outcome data, type of outcome data, 
choice of effect size, distribution of effect sizes, sensitivity to small-study effects or 
publication bias, and different meta-analytical approaches (e.g., Mantel-Haenszel, Peto or 
one-step methods). 
To date, limited evidence exists to inform which method performs best, especially 
when studies are few in number (<5), and given that the Bayesian intervals have not been 
assessed extensively in comparative studies. Overall, studies suggest that the HKSJ method 
has one of the best performance profiles. It performs well even in meta-analyses with fewer 
than 10 studies, 28 and is robust to the use of different estimators for the between-study 
variance and to changes in the magnitude of the between-study variance. 44,52 However, it 
should be considered that HKSJ is not always conservative compared to a fixed-effect meta-
analysis. 72 In case the estimated between-study variance is zero, the variance of the estimated 
overall effect size can be inaccurately small, and hence the HKSJ CI will be too narrow. 72 In 
such cases, it has been suggested to use the modified HKSJ to avoid inaccurate narrow CIs. 65 
Also, caution is needed in meta-analyses with rare events, where the HKSJ coverage has been 
found to be as low as 85% 52 and meta-analyses with fewer than 5 studies. 28 In the case of 
few studies, the modified HKSJ has been suggested, 75 but in the case of 𝑘 = 2 the modified 
HKSJ tends to be overconservative. 75,110 The likelihood based methods, and in particular the 
higher order methods Skovgaard statistic CI and Bartlett-type correction CI, are also 
associated with good coverage properties. 81 However, the higher order likelihood methods 
have never been compared directly to HKSJ, which would help make informed decisions on 
the CI selection. Alternatively, Bayesian intervals may be considered preferable to frequentist 
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intervals in situations where prior information is available and can be considered suitable for 
use in the meta-analysis. Bender et al. 28 recommend the use of the HKSJ method as a 
standard approach, but in case studies have considerably different precisions the modified 
HKSJ should be preferred. The same authors also suggest that when reliable prior 
information on the between-study variance is available, then the Bayesian intervals with 
(weakly) informative prior distributions for the heterogeneity should be preferred. 
The computation of prediction intervals in meta-analysis is also valuable, as they 
provide additional information about the overall effect size and we believe that they should 
be used more frequently. We propose a modification of the usual prediction interval with 
𝑡𝑘−2 to use 𝑡𝑘−1, under which CIs using the t-distribution (e.g., WTt and HKSJ CIs) and 
prediction intervals are identical when ?̂?2 = 0. Although some concerns have been raised 
about prediction intervals, including their actual coverage probability of the true effect in a 
new study and their sensitivity to distributional assumptions, 119,120 their advantages outweigh 
their disadvantages as they are a nice and easy way for people to interpret the implications of 
the between-study heterogeneity implied by their fitted model. A comprehensive simulation 
study assessing the different types of prediction intervals under a variety of meta-analytical 
scenarios and different between-study variance estimators would help critically examine the 
issues associated with the calculation and interpretation of prediction intervals. 
In conclusion, there are multiple methods to compute a CI for the overall effect size, 
and none of the methods clearly performs best across all meta-analytical settings. We hope 
that bringing them all together in one place will facilitate investigators in forming their own 
judgements about the most appropriate method for their needs. Overall, based on the existing 
literature and consensus among the co-authors of this paper, we tentatively suggest the 
application of the Hartung-Knapp-Sidik-Jonkman method as standard approach, at least in a 
meta-analysis with 5 or more studies. We recommend conducting a sensitivity analysis using 
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a variety of methods (with at least 2 to 3 methods) to assess the robustness of findings and 
conclusions, especially in a meta-analysis with fewer than 10 studies. It should be highlighted 
that these results refer to normally distributed true study-specific effects, and simulation 
studies are necessary to compare the performance of the 15 methods described in this review. 
For example, Kontopantelis and Reeves 131 used various non-normal distributions for the 
effect sizes and compared the WTz, WTqa, HKSJ, PL, BT, and FP methods. The authors 
showed that simulation results were broadly consistent across different effect size 
distributions (normally distributed, skew-normal, and extreme non-normal study-effects) with 
PL providing the best coverage, but with wide CI. Also, the FP method provided coverage 
close to the nominal level, regardless the included number of studies, at the expense of highly 
lengthy CIs.  The HKSJ method had a consistent 94% coverage for non-normal study-effects 
and small heterogeneity, but with larger heterogeneity the FP method performed better than 
the HKSJ CI. For a small number of studies (≤5), the WTz and PL methods performed best, 
with WTz outperforming PL only when the between-study variance was small. However, 
more simulation studies with non-normal true study-specific effects are required to draw 
robust conclusions for the 15 CIs across different meta-analytical scenarios. 
We also recommend the calculation of prediction intervals as a supplement to a CI to 
illustrate the degree of heterogeneity, particularly when large between-study heterogeneity is 
present. However, caution is needed for small between-study heterogeneity and unequal 
study sizes. In this case it is advisable to prefer prediction intervals derived in Bayesian 
framework using for example informative prior distributions. 20,21 Should any new methods 
become available, we recommend that these are compared to most, or ideally all, of the 
methods described in this review, and under the same circumstances both using real-life data 
and simulation studies. In Appendices 5 to 9 we present a selection of the identified methods 
for computing a CI to four illustrative, and contrasting, real data examples. We hope that our 
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codes presented in Appendices 7 and 8 can help to make this possible. This will help obtain a 
clearer picture about the performance of these methods when these are compared to each 
other. 
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Table 1 
Software options (with packages or macros) for each CI method. Το our knowledge, routines for WTqa (method 3), Bartlett-type correction 
(method 7), and ZL‖ (method 11) CIs are not available in any of the software options listed below. 
Software 
License 
Type 
Confidence/Credible interval Methods 
WTz  
(method 1) 
WTt 
(method 
2) 
HKSJ* 
(method 
4) 
Modified 
HKSJ 
(method 
5) 
PL 
(method 6) 
Skovgaard 
(method 8) 
HC‖‖ 
(method 
9) 
BT† 
(method 
10) 
Bootstrap 
(methods 
12, 13) 
FP 
(method 
14) 
Bayes 
(method 15) 
Comprehensive 
Meta-Analysis 
Commercial Yes - Yes - - - - - -  - 
Excel - 
MetaEasy 
AddIn 
Freeware Yes Yes - - Yes - - - - Yes - 
Excel - MetaXL 
AddIn 
Freeware Yes - - - - - - - - - - 
HLM Commercial - - - - Yes - - - - - - 
Meta-DiSc Freeware Yes - - - Yes - - - - - - 
Metawin Commercial Yes - - - - - - - Yes - - 
MIX Commercial Yes  - - - - - - - - - 
MLwin Freeware Yes  - - Yes - - - Yes  - Yes 
Open Meta 
Analyst 
Freeware Yes - - - - - - - -  - 
RevMan Freeware Yes - - - - - - - - - - 
R Freeware 
Yes 
MAd, 
meta, metafor,  
metagen, 
metalik, 
metamisc, 
metaSEM, 
Yes 
metaplus 
Yes 
MAd, 
meta, 
metafor, 
metamisc, 
metatest 
- 
Yes 
metaLik, 
metaplus 
Yes 
metaLik, 
metatest 
Yes 
metafor  
Yes 
metaxa†† 
Yes 
metaplus, 
boot 
Yes 
metafor 
 
Yes 
bayesmeta§, 
blme, BRugs, 
gemtc, 
metamisc 
R2WinBUGS, 
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metatest, 
metaplus, 
mvmeta,  
mvtmeta, 
netmeta, 
rmeta 
SASBUGS 
rjugs   
SAS Commercial 
Yes 
marandom.sas, 
PROCs GLM 
and MIXED 
Yes 
PROCs 
GLM 
and 
MIXED 
- - 
Yes 
marandom.sas, 
PROC NLP 
- - - - - 
Yes 
PROC 
MCMC 
Stata Commercial 
Yes 
metaan, metan, 
metareg, 
mvmeta, xtreg 
- - 
Yes 
metareg 
Yes 
gllamm, metaan  
- - - 
Yes 
bootstrap 
Yes 
metaan 
- 
SPSS Commercial 
Yes 
meanes.sps, 
metaf.sps, 
metareg.sps 
- - - - - - - - - - 
BUGS, 
OpenBUGS, 
WinBUGS  
Freeware -  - 
 
- - - - -  Yes 
‖ A resampling test is available in the R package metatest 64. 
‖‖ Henmi and Copas 30 provide an R code to implement the HC method. 
* IntHout et al 16 provide an approach to easily convert WTz CIs to HKSJ CIs. 
† Biggerstaff and Tweedie 85 provide a SAS code to implement the BT method. 
†† This package uses the exact random-effects weights in the Biggerstaff and Tweedie approach. 86 
§ Bayesian approaches can be implemented using the Markov Chain Monte Carlo (MCMC) techniques in several software, such as OpenBUGS,127 WinBUGS128  or without 
MCMC as described by Turner et al, 99 in the R package bayesmeta. 101  
 
Comprehensive Meta-Analysis132  www.meta-analysis.com/  
Excel using the MetaEasy AddIn133  https://www.jstatsoft.org/article/view/v030i07 or MetaXL AddIn http://www.epigear.com/  
HLM 134 http://www.ssicentral.com/hlm/   
Meta-DiSc135  ftp://ftp.hrc.es/pub/programas/metadisc/  
Metawin136  http://www.metawinsoft.com/  
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MIX137  www.mix-for-meta-analysis.info/  
MLwin138 http://www.bristol.ac.uk/cmm/software/mlwin/  
Open Meta Analyst139  http://www.cebm.brown.edu/openmeta/ 
RevMan130  www.cochrane.org/  
R140http://www.r-project.org/ Packages: bayesmeta, 101 blme, 141 boot, 124,125 BRugs, 142 Mad, 143 mada, 144 meta, 114 gemtc, 145 metafor, 113 metagen, 146 metaLik, 
63,123 metamisc, 147 metaplus, 148 metaSEM, 149 metatest, 64,150 metaxa, 86 mvmeta, 151 mvtmeta, 152 netmeta, 153) R2WinBUGS, 154 rjugs, 142 rmeta 155 
SAS156  http://www.sas.com/technologies/analytics/statistics/stat/  Macros: marandom.sas, 157 PROC IML, 158 PROC MIXED, 159,160 PROC GLIMMIX, 161 
SASBUGS,162  RASmacro, 163 PROC MCMC164 
Stata165 www.stata.com / Routines: bootstrap, 166 gllamm,167 metaan,168 metareg,126 metan,115 mvmeta,116 xtreg, 169 
SPSS170 http://www.spss.co.in/ Macros: meanes.sps, 171 metaf.sps, 172 metareg.sps 173 
BUGS, 174  OpenBUGS, 127 WinBUGS128  www.mrc-bsu.cam.ac.uk/bugs/  
 
ABBREVIATIONS: BT, Biggerstaff and Tweedie; FP, Follmann and Proschan; HC, Henmi and Copas; HKSJ, Hartung-Knapp/Sidik-Jonkman; PL, Profile 
likelihood; WTz, Wald-type with a normal distribution; WTt, Wald-type with a t distribution; WTqa, Quantile approximation; ZL, Zeng and Lin  
 
 
